Abstract
Gout is a painful disease of joints generated because of the deposition of urate crystals within the joints. Uricase is an enzyme capable of degrading less water soluble urate crystals into a compound allantoin, which is more water soluble and hence is easily excreted. Uricase being proteinaceous is degraded by the protein digestive enzymes of gastro intestinal tract (GIT) when administered orally. Colonic part of GIT lacks protein digestive enzymes and thus provides suitable conditions for the absorption of uricase. Colon consists of several microbial flora which secrete enzymes capable of degradation of alginates and pectin which are not digested by upper GI tract. Eudragit S-100 (pH sensitive polymer) coated alginate – pectinate microbeads were found to be effective for delivery of uricase directly to the colonic site. Sodium taurocholate, a bile salt, was found to be suitable for the effective absorption of uricase from colonic site into the systemic circulation.
Keywords: Colon targeting, Enzyme, Enzyme therapy, Gout, Hyperuricemia, Microbeads, Uricase.
Drug Delivery Letters
Title:Fabrication and Evaluation of Colon Targeted Uricase Containing Microbeads for Treatment of Gout
Volume: 3 Issue: 1
Author(s): Harinath Dwivedi, Kusum Agarwal and Shubhini A Saraf
Affiliation:
Keywords: Colon targeting, Enzyme, Enzyme therapy, Gout, Hyperuricemia, Microbeads, Uricase.
Abstract: Gout is a painful disease of joints generated because of the deposition of urate crystals within the joints. Uricase is an enzyme capable of degrading less water soluble urate crystals into a compound allantoin, which is more water soluble and hence is easily excreted. Uricase being proteinaceous is degraded by the protein digestive enzymes of gastro intestinal tract (GIT) when administered orally. Colonic part of GIT lacks protein digestive enzymes and thus provides suitable conditions for the absorption of uricase. Colon consists of several microbial flora which secrete enzymes capable of degradation of alginates and pectin which are not digested by upper GI tract. Eudragit S-100 (pH sensitive polymer) coated alginate – pectinate microbeads were found to be effective for delivery of uricase directly to the colonic site. Sodium taurocholate, a bile salt, was found to be suitable for the effective absorption of uricase from colonic site into the systemic circulation.
Export Options
About this article
Cite this article as:
Dwivedi Harinath, Agarwal Kusum and Saraf Shubhini A, Fabrication and Evaluation of Colon Targeted Uricase Containing Microbeads for Treatment of Gout, Drug Delivery Letters 2013; 3 (1) . https://dx.doi.org/10.2174/2210304x11303010007
DOI https://dx.doi.org/10.2174/2210304x11303010007 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biomedical Data Integration in Computational Drug Design and Bioinformatics
Current Computer-Aided Drug Design A2A Adenosine Receptor and its Modulators: Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and Antagonists
Current Pharmaceutical Design Evaluation of Biological Effects and Toxicity of Cetyltrimethylammonium Bromide Stabilized Silver Nanoparticles and Cetyltrimethylammonium Bromide Alone Following Intravenous Injection in Mice
Current Nanomedicine The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells
Current Cancer Drug Targets Antineoplastic Activity of Monocrotaline Against Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Cell Proliferation and Cytotoxicity Assays
Current Pharmaceutical Biotechnology Functional Nanoplatforms for Enhancement of Chemotherapeutic Index
Anti-Cancer Agents in Medicinal Chemistry Ligand-Based Pharmacophore Modeling, Atom-Based 3D-QSAR and Molecular Docking Studies on Substituted Thiazoles and Thiophenes as Polo-Like Kinase 1 (Plk1) Inhibitors
Combinatorial Chemistry & High Throughput Screening Role of Inflammatory Mediators in Angiogenesis
Current Drug Targets - Inflammation & Allergy Gene Therapy in Liver Diseases: State-of-the-Art and Future Perspectives
Current Gene Therapy Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis
Current Pharmaceutical Design The Anticancer Face of Interferon Alpha (IFN-Alpha): From Biology to Clinical Results, with a Focus on Melanoma
Current Medicinal Chemistry New Concepts for Glaucoma Implants - Controlled Aqueous Humor Drainage, Encapsulation Prevention and Local Drug Delivery
Current Pharmaceutical Biotechnology Let-7a Could Serve as A Biomarker for Chemo-Responsiveness to Docetaxel in Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy
Current Pharmaceutical Design Cancer Pharmacogenomics: Germline DNA, Tumor DNA, or Both?
Current Pharmacogenomics Anti-Angiogenic Therapy as a Cancer Treatment Paradigm
Current Medicinal Chemistry - Anti-Cancer Agents Target Genetic Abnormalities for the Treatment of Colon Cancer and Its Progression to Metastasis
Current Drug Targets The Recent Progresses on The Improved Therapy of Melanoma by Novel Drug Delivery Systems
Current Drug Targets The Flavin-Containing Monoooxygenases (FMOs): Genetic Variation and its Consequences for the Metabolism of Therapeutic Drugs
Current Pharmacogenomics